Journal Annals of the New York Academy of Sciences.
Journal Annals of the New York Academy of Sciences. Volume 795. Pages xiii-xix. Publication Date 31 October 1996.
Introductory Remarks Sonya Dougal, PhD, New York Academy of Sciences Scott Brodeur, PhD, Bristol-Myers Squibb. 9:15 AM. Keynote Address Interleukin-2 (IL-2) as Treatment for Renal Cell Carcinoma and Melanoma Dr. James Mier, MD, Beth Israel Deaconess Medical Center, Harvard Medical School. 9:55 AM. Theoretical and Experimental Analysis of Immunocytokine Biodistribution at the Cellular Level K. Dane Wittrup, PhD, Massachusetts Institute of Technology. 10:35 AM. Networking Coffee Break.
New York Academy of Sciences (Corporate Author). Inc. Genetics Institute (Corporate Author).
Details (if other): Cancel. Thanks for telling us about the problem. Interleukin 12: Cellular And Molecular Immunology Of An Important Regulatory Cytokine. New York Academy of Sciences (Corporate Author).
Annals of the New York Academy of Sciences
Annals of the New York Academy of Sciences. Volume 795, Interleukin 12: Cellular and Molecular Immunology of an Important Regulatory Cytokine pages 100–115, October 1996. Studies of the cytokine profile during the primary response revealed that IL-12 induced in spleen cells the capacity to express both IL-4 and IFN-gamma.
Microbiology and Immunology, Department of. Поиск в DSpace.
The Annals of the New York Academy of Sciences is an academic journal published by Wiley-Blackwell on behalf of the New York Academy of Sciences. It is one of the oldest science journals still being published, having been founded in 1823. Each issue is of substantial length and explores a single topic with a multidisciplinary approach
New, Used & Rental Textbooks. Medicine & Health Sciences. The 13-digit and 10-digit formats both work.
New, Used & Rental Textbooks.
Gately et a. Interleukin-12 Antagonist Activity of Mouse Interleukin-12 p40 Homodimer in Vitro and in Vivo, Annals New York Academy of Sciences, 795:1-12 (1996). Germann et a. IL-12, a Cytokine with Multiple Effects on TH1-, but not on TH2-cells, Immunobiology, 186:38 (1992). Godfrey et a. A Developmental Pathway Involving Four Phenotypically and Functionally Distinct Subsets of CD3−CD4−CD8− Triple-Negative Adult Mouse Thymocytes Defined by CD44 and CD25 Expression, The Journal of Immunology, 150:4244-4252 (1993).
Annals of the New York Academy of Sciences. The presence of interleukin 4 during in vitro priming determines the potential of CD4+ T cells from T cell receptor transgenic mice. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. Enrico Maggi, Paola Parronchi, +6 authors Sergio Romagnani. Journal of immunology.
Brooke Grindlinger, PhD Director, Life Sciences The New York Academy of Sciences 3 FACULTY DISCLOSURES All faculty participating in this activity are required to disclose to the audience any significant financial interest.
Brooke Grindlinger, PhD Director, Life Sciences The New York Academy of Sciences 3 FACULTY DISCLOSURES All faculty participating in this activity are required to disclose to the audience any significant financial interest and/or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in his/her presentation and/or the commercial contributor(s).